Abstract:Abstract Objectives Carbon-14 ( 14 C) labeling is a standard technology for tracing molecules and providing their pharmacokinetic profiles. However, its primary focus has been on small molecules, with limited application to biomacromolecules. Particularly in the development of new biological entities (NBE), the utilization of microdosing with a 14 C-labeled biomacromolecule proves beneficial in the early stages of drug development, contributing to significant time and cost savings. This study investigates the 14 C-labeling of antibody and explores the stability of 14 C-labeled antibody under various storage conditions. Methods and results In this study, the utilization of 14 C-formaldehyde for labeling target antibodies at various molar ratios revealed a direct correlation between labeling efficiency and the quantity of 14 C-formaldehyde applied: 1.5 mol/mol for 14 C-labeled antibody with the use of 10 equivalents of 14 C-formaldehyde, 3.8 mol/mol for 14 C-labeled antibody with the use of 10 equivalents of 14 C-formaldehyde, and 10.5 mol/mol for 14 C-labeled antibody with the use of 60 equivalents of 14 C-formaldehyde. All the reaction conditions exhibited no antibody degradation, as evidenced by the absence of a significant change in HPLC purity compared to the unlabeled antibody. Stability tests revealed that all groups maintained their purities over a 4-week period at both − 75 ± 10 °C and 5 ± 3 °C. Given safety concerns related to internal radiation exposure in potential human subjects during microdosing, this study established optimal conditions for employing 14 C-labeled antibodies. Therefore, it is optimized that 10 equivalents of 14 C-formaldehyde can be used for 14 C-antibody labeling through reductive amination, storing the antibodies at 5 ± 3 °C, and assigning a storage period of 4 weeks. Conclusion The findings from this study offer valuable insights into the effective application of 14 C-labeling in microdosing studies, especially for larger molecules such as antibodies.

Carbon‐14 Labeling Synthesis of RORγt Inhibitor JNJ‐61803534

Synthesis Of Carbon-14 Labeled Pyraoxystrobin, A Novel Fungicide

Synthesis of Carbon-14 Labeled ZJ0712, a Novel Strobilurin Fungicide

Radiolabeled Synthesis and Identification of A Novel Herbicide, Propyl 4-[2-(4,6-dimethoxy-2-pyrimidinyloxy)benzylamino]benzoate with All Six Benzoic Ring Carbons Labeled by C-14

Synthesis and Analysis of Carbon-14 Labelled Imidacloprid With High Specific Activity

Synthesis and Analysis of Two Versions of Radioisotope Carbon-14 Labelled Dufulin

Synthesis and analysis of carbon-14 labelled Dufulin with high specific activity

Synthesis of Herbicidal Zj0273 Labeled with Tritium and Carbon-14

Nitrilase mediated mild hydrolysis of a carbon-14 nitrile for the radiosynthesis of 4-(7-hydroxycarbamoyl-[1-14 C-heptanoyl]-oxy)-benzoic acid methyl ester, [14 C]-SHP-141: A novel class I/II histone deacetylase (HDAC) inhibitor

A Study of the Radiosynthesis of Fac-[188Re(co)3(h2o)3]+ and Its Application in Labeling 1,2,3-Triazole Analogs Obtained by Click Chemistry

Automated Synthesis of Fluorine-18 Labeled CXCR4 Ligand via the Conjugation with Nicotinic Acid N-Hydroxysuccinimide Ester (6-[18F]SFPy)

Synthesis and Identification of 14 C Labelled Pyraoxystrobin

A metal-catalysed functional group metathesis approach to the carbon isotope labelling of carboxylic acids

Efficient palladium-catalyzed electrocarboxylation enables late-stage carbon isotope labelling

A Combined Simple Bubbling Method with High Performance Liquid Chromatography Purification Strategy, Higher Radiochemical Yield and Purity and Faster Preparation of Carbon-11-raclopride.

An Overview of Radio or Stable Isotope‐labeled Cis‐neonicotinoid Analogs

Carbon Dioxide Radical Anion by Photoinduced Equilibration between Formate Salts and [11C, 13C, 14C]CO2: Application to Carbon Isotope Radiolabeling

Synthesis of 13C‐ and 14c‐labelled Catechol

Simplified one-pot 18F-labeling of biomolecules with in situ generated fluorothiophosphate synthons in high molar activity

A Simple and Efficient Automated Cgmp‐compliant Radiosynthesis of [11c]metomidate Using Solid Phase Extraction Cartridge Purification

Method development for 14C-labeling of IgG antibodies in preparation for clinical trials